It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The incidence of insulin resistance (IR) and hepatic steatosis is increasing, with dietary fiber playing a protective role against these disorders. Ocimum basilicum L., widely used in food, pharmaceutical, and cosmetic industries, but their health-promoting properties remain underexplored. This study evaluated the effects of a fiber-rich fraction of partially defatted basil seeds (BSF) on IR, hepatic steatosis, and polyunsaturated fatty acid and short-chain fatty acid (SCFA) profiles in high-fat diet (HFD)-fed C57BL/6 J male mice. Mice were assigned to four groups and fed either a control diet or HFD, supplemented with BSF or oat flour for 4 weeks. HFD induced IR, hepatic steatosis, proinflammatory state, and a significant decreased in SCFA production. In contrast, supplementation with BSF attenuated IR, steatosis, liver damage, oxidative stress, and inflammation, while increasing n-3 polyunsaturated fatty acids in liver, adipocytes, and erythrocytes, and enhancing SCFA production, suggesting potential therapeutic benefits in managing these conditions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 University of Chile, Nutrition Department, Faculty of Medicine, Santiago, Chile (GRID:grid.443909.3) (ISNI:0000 0004 0385 4466)
2 Universidad San Sebastián, School of Health Care Sciences , Puerto Montt, Chile (GRID:grid.442215.4) (ISNI:0000 0001 2227 4297)
3 Pontificia Universidad Católica de Valparaíso, School of Agronomy, Faculty of Agronomy and Food Sciences , Quillota, 2260000, Chile (GRID:grid.8170.e) (ISNI:0000 0001 1537 5962)
4 University of Chile, Nutrition Department, Faculty of Medicine, Santiago, Chile (GRID:grid.443909.3) (ISNI:0000 0004 0385 4466); Facultad Medicina, Universidad Andrés Bello, Medicina, Santiago, Chile (GRID:grid.412848.3) (ISNI:0000 0001 2156 804X)
5 Universidad Central de Chile, Food Science Lab, Faculty of Medicine and Health Sciences, Santiago, Chile (GRID:grid.440619.e) (ISNI:0000 0001 2111 9391)
6 Center of Interdisciplinary Biomedical and Engineering Research for Health-MEDING. Universidad de Valparaíso, Valparaíso, Chile (GRID:grid.412185.b) (ISNI:0000 0000 8912 4050); University of Chile, Medical Technology Department, Faculty of Medicine, Santiago, Chile (GRID:grid.443909.3) (ISNI:0000 0004 0385 4466)
7 Universidad de Chile, Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, Faculty of Medicine, Santiago, Chile (GRID:grid.443909.3) (ISNI:0000 0004 0385 4466)